Relatively low primary drug resistant tuberculosis in southwestern Ethiopia

<p>Abstract</p> <p>Background</p> <p>The prevalence of drug resistant tuberculosis (TB) in Ethiopia in general, and Jimma area in particular, is not well documented. We conducted a study at Jimma University specialized hospital in southwest Ethiopia among new cases of s...

Full description

Bibliographic Details
Main Authors: Abebe Gemeda, Abdissa Ketema, Abdissa Alemseged, Apers Ludwig, Agonafir Mulualem, de-Jong Bouke C, Colebunders Robert
Format: Article
Language:English
Published: BMC 2012-05-01
Series:BMC Research Notes
Subjects:
id doaj-d22820f6fa3f4b8686b7c65b028404fd
record_format Article
spelling doaj-d22820f6fa3f4b8686b7c65b028404fd2020-11-25T02:14:06ZengBMCBMC Research Notes1756-05002012-05-015122510.1186/1756-0500-5-225Relatively low primary drug resistant tuberculosis in southwestern EthiopiaAbebe GemedaAbdissa KetemaAbdissa AlemsegedApers LudwigAgonafir Mulualemde-Jong Bouke CColebunders Robert<p>Abstract</p> <p>Background</p> <p>The prevalence of drug resistant tuberculosis (TB) in Ethiopia in general, and Jimma area in particular, is not well documented. We conducted a study at Jimma University specialized hospital in southwest Ethiopia among new cases of smear positive TB patients to determine the pattern of resistance to first-line drugs.</p> <p>Methods</p> <p>A health institution based cross sectional study was conducted from November 2010 to September 2011. Any newly diagnosed smear positive TB patient 18 years and above was included in the study. Demographic and related data were collected by trained personnel using a pretested structured questionnaire. Mycobacterial drug susceptibility testing (DST) to the first line drugs isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and streptomycin (STM) was performed on cultures using the indirect proportion method. <it>M. tuberculosis</it> complex (MTBC) was identified with the Capilia TB-Neo test.</p> <p>Results</p> <p>136 patients were enrolled in the study. Resistance to at least one drug was identified in 18.4%. The highest prevalence of resistance to any drug was identified against INH (13.2%) followed by STM (8.1%). There was no statistically significant difference in the proportion of any resistance by sex, age, HIV status and history of being imprisoned. The highest mono resistance was observed against INH (7.4%). Mono resistance to streptomycin was associated with HIV infection (crude OR 15.63, 95%CI: 1.31, 187). Multidrug-resistance TB (MDR-TB) was observed in two patients (1.5%).</p> <p>Conclusion</p> <p>Resistance to at least one drug was 18.4% (INH-13.2% and STM-8.1%). STM resistance was associated with HIV positivity. There was relatively low prevalence of MDR-TB yet INH resistance was common around Jimma. The capacity of laboratories for TB culture and DST should be strengthened, in order to correctly manage TB patients and avoid amplification of drug resistance.</p> TuberculosisDrug resistanceEthiopiaJimma
collection DOAJ
language English
format Article
sources DOAJ
author Abebe Gemeda
Abdissa Ketema
Abdissa Alemseged
Apers Ludwig
Agonafir Mulualem
de-Jong Bouke C
Colebunders Robert
spellingShingle Abebe Gemeda
Abdissa Ketema
Abdissa Alemseged
Apers Ludwig
Agonafir Mulualem
de-Jong Bouke C
Colebunders Robert
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia
BMC Research Notes
Tuberculosis
Drug resistance
Ethiopia
Jimma
author_facet Abebe Gemeda
Abdissa Ketema
Abdissa Alemseged
Apers Ludwig
Agonafir Mulualem
de-Jong Bouke C
Colebunders Robert
author_sort Abebe Gemeda
title Relatively low primary drug resistant tuberculosis in southwestern Ethiopia
title_short Relatively low primary drug resistant tuberculosis in southwestern Ethiopia
title_full Relatively low primary drug resistant tuberculosis in southwestern Ethiopia
title_fullStr Relatively low primary drug resistant tuberculosis in southwestern Ethiopia
title_full_unstemmed Relatively low primary drug resistant tuberculosis in southwestern Ethiopia
title_sort relatively low primary drug resistant tuberculosis in southwestern ethiopia
publisher BMC
series BMC Research Notes
issn 1756-0500
publishDate 2012-05-01
description <p>Abstract</p> <p>Background</p> <p>The prevalence of drug resistant tuberculosis (TB) in Ethiopia in general, and Jimma area in particular, is not well documented. We conducted a study at Jimma University specialized hospital in southwest Ethiopia among new cases of smear positive TB patients to determine the pattern of resistance to first-line drugs.</p> <p>Methods</p> <p>A health institution based cross sectional study was conducted from November 2010 to September 2011. Any newly diagnosed smear positive TB patient 18 years and above was included in the study. Demographic and related data were collected by trained personnel using a pretested structured questionnaire. Mycobacterial drug susceptibility testing (DST) to the first line drugs isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and streptomycin (STM) was performed on cultures using the indirect proportion method. <it>M. tuberculosis</it> complex (MTBC) was identified with the Capilia TB-Neo test.</p> <p>Results</p> <p>136 patients were enrolled in the study. Resistance to at least one drug was identified in 18.4%. The highest prevalence of resistance to any drug was identified against INH (13.2%) followed by STM (8.1%). There was no statistically significant difference in the proportion of any resistance by sex, age, HIV status and history of being imprisoned. The highest mono resistance was observed against INH (7.4%). Mono resistance to streptomycin was associated with HIV infection (crude OR 15.63, 95%CI: 1.31, 187). Multidrug-resistance TB (MDR-TB) was observed in two patients (1.5%).</p> <p>Conclusion</p> <p>Resistance to at least one drug was 18.4% (INH-13.2% and STM-8.1%). STM resistance was associated with HIV positivity. There was relatively low prevalence of MDR-TB yet INH resistance was common around Jimma. The capacity of laboratories for TB culture and DST should be strengthened, in order to correctly manage TB patients and avoid amplification of drug resistance.</p>
topic Tuberculosis
Drug resistance
Ethiopia
Jimma
work_keys_str_mv AT abebegemeda relativelylowprimarydrugresistanttuberculosisinsouthwesternethiopia
AT abdissaketema relativelylowprimarydrugresistanttuberculosisinsouthwesternethiopia
AT abdissaalemseged relativelylowprimarydrugresistanttuberculosisinsouthwesternethiopia
AT apersludwig relativelylowprimarydrugresistanttuberculosisinsouthwesternethiopia
AT agonafirmulualem relativelylowprimarydrugresistanttuberculosisinsouthwesternethiopia
AT dejongboukec relativelylowprimarydrugresistanttuberculosisinsouthwesternethiopia
AT colebundersrobert relativelylowprimarydrugresistanttuberculosisinsouthwesternethiopia
_version_ 1724901907488571392